Busca un médico

John J. Weroha, M.D., Ph.D.

  1. Internist
  2. Oncologist

Saravut J. Weroha, M.D., Ph.D., is a medical oncologist focusing primarily on gynecologic malignancies and phase 1 clinical trials. His specific areas of clinical focus include:

  • Personalized cancer therapy using ovarian cancer patient-derived xenografts (PDXs), also known as Cancer Avatars, to accurately predict response to anti-cancer treatment.
  • Implementing a multidisciplinary approach to cancer care for strategic utilization of anticancer therapies, such as surgery, radiation, ablation, embolization, and chemotherapy.
  • Searching for molecular targeted therapies based on the specific genetic aberrations found within individual tumors by state-of-the-art next-generation sequencing techniques.
  • Selection of clinical trials that fit the patient's tumor type, molecular profile, and goals of care. This requires careful consideration of individual social factors as well as tumor biology.
  • Above all, working closely with patients as a guide to devise a therapeutic plan which is most optimal for the needs of our patients.

Dr. Weroha works to bridge the gap between promising new therapies in the laboratory and ultimately FDA approval of new therapies for patients with cancer.

  1. Gynecologic cancer
  • Gynecologic oncology
  • Animal surrogates of human tumors (avatars)
  1. 2013
    FellowHematology/Oncology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  2. 2011
    ResidentClinician Investigator, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  3. 2010
    Internship/Residency - Internal Medicine, Clinical Investigator ProgramInternal Medicine, Mayo School of Graduate Medical Education
  4. 2010
    ResidentInternal Medicine, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  5. 2007
    MDUniversity of Kansas School of Medicine
  6. 2007
    PhD - Pharmacology, Toxicology and TherapeuticsUniversity of Kansas School of Medicine
  7. 1998
    BS - Cellular Biology, with Honors and DistinctionUniversity of Kansas


  1. 2013
    Medical OncologyAmerican Board of Internal Medicine

Awards and honors

  1. 2010
    ChiefClinical Investigator Program, Mayo Graduate School of Medicine, Mayo Clinic College of Medicine and Science
  2. 2005
    Dissertation Defense with HonorsUniversity of Kansas
  3. 2004
    Best Presentation of Graduate, Medical, and Allied Health Schools at KUMCSigma Xi, The Scientific Research Society
  4. 2004
    Best Graduate Student Presentation in the School of MedicineStudent Research Forum, University of Kansas
  5. 2003
    Comprehensive Exam with HonorsDepartment of Pharmacology and Toxicology, University of Kansas
  6. 1998
    Departmental Honors in BiologyUniversity of Kansas
  7. 1998
    Graduation with Distinction (Top 10%)University of Kansas
  8. 1998
    Outstanding Honors Research ThesisUniversity of Kansas

Professional memberships

  1. 2023 - present
    Early Faculty Development ChairExecutive Committee, Department of Oncology
  2. 2023 - present
    Translational Science Program LeadMayo Clinic Comprehensive Cancer Center
  3. 2023 - present
    Associate MemberNational Cancer Institute, National Institutes of Health
  4. 2023 - present
    Emerging Leader for Research ProgramsMayo Clinic Comprehensive Cancer Center
  5. 2022 - present
    Basic ScientistNational Cancer Institute, National Institutes of Health
  6. 2022 - present
    MemberSociety of Gynecologic Oncologists
  7. 2021 - present
    Grant ReviewerThe Austrian Science Fund (FWF)
  8. 2021 - 2022
    MemberMayo Clinic Comprehensive Cancer Center
  9. 2021 - present
    Ad Hoc Grant ReviewerUnited States Department of Defense
  10. 2019 - present
    MemberNRG Oncology, Ovarian Committee
  11. 2019 - present
    Assistant DirectorMayo Medical School
  12. 2019 - present
    MemberNRG Oncology Ovarian Cancer Committee
  13. 2018 - present
    Co-ChairMayo Clinic Comprehensive Cancer Center
  14. 2018
    Grant ReviewerBreast Cancer Now
  15. 2018 - 2020
    Expert ConsultantWatson Clinical Trial Matching Committee
  16. 2018 - present
    Executive Committee MemberMayo Clinic Ovarian Cancer SPORE
  17. 2017 - 2019
    MemberMayo Medical School
  18. 2017 - present
    Grant ReviewerMayo Clinic Ovarian Cancer SPORE
  19. 2017 - present
    Grant ReviewerFraternal Order of Eagles
  20. 2016
    Grant ReviewerDutch Cancer Society (KWF Kankerbestrijding)
  21. 2016 - present
    Medical Advisory Board - MemberMinnesota Ovarian Cancer Alliance
  22. 2015 - present
    DirectorMayo Clinic Ovarian Cancer SPORE
  23. 2015 - 2023
    MemberMayo Clinic Comprehensive Cancer Center
  24. 2014 - 2017
    Clinical Trials AuditorMayo Clinic Comprehensive Cancer Center
  25. 2013 - present
    MemberDivision of Medical Oncology, Department of Oncology
  26. 2010 - present
    MemberAmerican Society of Clinical Oncology
  27. 2001 - present
    MemberAmerican Association for Cancer Research (AACR)


Research activities

See a description of research activities.